Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome

计划入组 40 人 · 首次发布于 2020 年 2 月 10 日

Treatment Failure of Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea Syndrome (OSA): A Trial Comparing Polysomnography and the Sunrise Device to Drive Treatment-Adjustment Decisions.

计划入组 105 人 · 首次发布于 2026 年 4 月 15 日

The Sunrise OSA Trial

计划入组 40 人 · 首次发布于 2022 年 1 月 24 日

LLC-0424

IB-RA (Innobioscience LLC)

Gln28Exenatide(Prolynx LLC)

Sunrise Medical Supply, Inc.

United States

Sunrise Pharmaceutical Inc

United States

SUNRISE TRADING CO

India

Robotic Wheelchair Market to Reach USD 425.72 Million by 2035, Driven by AI Navigation and Brain-Computer Interfaces

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases